ARCADIA study protocol: a phase II, randomised, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of AZD1656 in patients with diabetes hospitalised with suspected or confirmed COVID-19

• Michelle Allen,
• Kieran Mccafferty,
• Zoe Hollowood,
• Donna Lockhart,
• Jamie Chorlton

Affiliations

Michelle Allen

Department of Nephrology, Barts Health NHS Trust, London, UK

Kieran Mccafferty

Department of Nephrology, Barts Health NHS Trust, London, UK

Zoe Hollowood

St George Street Capital, London, UK

Donna Lockhart

St George Street Capital, London, UK

Jamie Chorlton

St George Street Capital, London, UK